Protagonist Therapeutics, Inc. (PTGX)
134.58
+5.83
(+4.53%)
USD |
NASDAQ |
Oct 19, 16:00
134.58
0.00 (0.00%)
After-Hours: 20:00
Protagonist Therapeutics Profit Margin (Quarterly) : 76.28% for June 30, 2026
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 76.28% |
| March 31, 2026 | 6.71% |
| December 31, 2025 | -596.8% |
| September 30, 2025 | -834.9% |
| June 30, 2025 | -627.0% |
| March 31, 2025 | -41.15% |
| December 31, 2024 | 77.17% |
| September 30, 2024 | -710.4% |
| June 30, 2024 | -734.7% |
| March 31, 2024 | 81.32% |
| December 31, 2023 | 45.56% |
| September 30, 2023 | |
| June 30, 2023 | |
| March 31, 2023 | |
| December 31, 2022 | |
| September 30, 2022 | |
| June 30, 2022 | -4.78K% |
| March 31, 2022 | -81.37% |
| Date | Value |
|---|---|
| December 31, 2021 | -428.3% |
| September 30, 2021 | -328.6% |
| June 30, 2021 | -1.36K% |
| March 31, 2021 | -387.8% |
| December 31, 2020 | -334.3% |
| September 30, 2020 | -59.20% |
| June 30, 2020 | -312.4% |
| March 31, 2020 | -550.6% |
| December 31, 2019 | -643.7% |
| September 30, 2019 | -396.3% |
| June 30, 2019 | |
| March 31, 2019 | -904.0% |
| December 31, 2018 | -589.2% |
| September 30, 2018 | -142.8% |
| June 30, 2018 | -74.21% |
| March 31, 2018 | -71.06% |
| December 31, 2017 | -27.05% |
| September 30, 2017 | -54.95% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Johnson & Johnson | 0.83% |
| AbbVie, Inc. | 21.21% |
| Gilead Sciences, Inc. | -134.2% |
| Alnylam Pharmaceuticals, Inc. | 12.74% |
| BioMarin Pharmaceutical, Inc. | 4.49% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | 12.10% |
| Return on Assets | 11.29% |
| Return on Invested Capital | 11.92% |
| Gross Profit Margin (Quarterly) | 99.81% |
| Operating Margin (Quarterly) | 74.37% |
| Return on Net Operating Assets | 229.0% |